000 01036 a2200229 4500
005 20250517163254.0
264 0 _c20181023
008 201810s 0 0 eng d
022 _a1433-7339
024 7 _a10.1007/s00520-017-3809-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOkumura, Lucas Miyake
245 0 0 _aHow to report adherence to treatment as clinically relevant data-making a case of CML and TKI.
_h[electronic resource]
260 _bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_c02 2018
300 _a323-324 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
650 0 4 _aProtein Kinase Inhibitors
773 0 _tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_gvol. 26
_gno. 2
_gp. 323-324
856 4 0 _uhttps://doi.org/10.1007/s00520-017-3809-2
_zAvailable from publisher's website
999 _c27359279
_d27359279